Member Info for leas

Strider, doesn't get much better than this. RvR is excellent. Current shareholders will be reluctant to sell at the current MC with the potential upside. If Cal-1 is a success then the anticipation of Sol-1 beggars belief.

I see that they have extended the date for bidders for the civil Works for Production Facilities in Mariposa-1 Well in the CPO-5 block. Now the 5th March.

TCW, thank you.. great post

Maybe a rise but not all hangs on this 1 drill. Cos probably higher than Sol-1. I think value here will be added as the drilling programme progresses with the likelihood of a couple of setbacks. That said, I'm just guessing that is how it will playout but intend being invested throughout.

Tom, I don't think they will be in a few days. Maybe towards the end of week 1 of March or week 2. That said, they may issue one if there are oil shows but looks like a typical Friday trading day to me.

Price of oil is in dollars. Whether or not your invested in shares, we all invest in foreign currencies. A weaker sterling can actually help a company.

Just hope this bb doesn't start to mirror the Lloyds chat.

Likewise, thanks for the update. Like bigsmoke I would have expected our own RNS, if nothing else, good PR. That said, things are just getting better and better here.

I sold MTFB after the P3 result due to the massive discount they offered the city on their placing. From memory the sp was 39p and the company placed shares at 31p. I would wait until finance details are announced.

The traders have moved on now. or those that got spiked are reluctant holders. One observation which may be of interest to the LTH's are the FDA's approach to managing risk. When I was invested in another bio conducting P3 trials I was informed that the FDA accept that all medicines carry risks and as long as the benefit outweigh the risks then it would get approval. I was also informed that in areas of an urgent need for a drug then that approval should be given priority. Imo, stage 4 will come, despite the setback all shareholders long term or not should see a profit, so anyone thinking of investing should try and get the best possible entry price.
Timeframes in this sector are so so slow, no need to rush into investment decisions. All the very best to investors here.

Certainly does not underpin the sp. but if it confirms that it is the same field then I just cannot see this being ignored anymore. Our seller may not be done yet but I'm sure they will be history if Cal-1 is successful. Those shares will be in very sticky hands going forward.

Sadly, a lot of investors are noting more than gamblers. Ignore the fundamentals but seek out a quick 10% profit. MTFB is a typical mindset of today's investor. FLYB another, queuing up to invest their hard earned cash into a failing business on the hope of a takeover. Now that offer is 1p they are queuing up blaming everybody else other than themselves. The herd will be back soon.Informing investors that they will not sell until it reaches a pound as they pick up their phone to the broker and sell.

Just make sure that if you buy it's large enough to clear our seller. :)

Morning guys, my average is 99p having bought last summer. My dividends have already put me in profit. Cannot see much of a downside but conversely cannot see much of an upside. That's said, we don't know if Brexit will deter many from travelling abroad this summer which may help the business. Also the outside chance of further consolidation in the industry.

The loyalty card is of no real use to me as I live in France for most of the year but happy to hold and keep accepting the cheques.

However, IMM raised a significant amount of cash prior to P3 readout and bought themselves a lot of time. The trial failed because the FDA set the bar too high on the SLEDAI score. It did help all of those patients given Lupuzor with NO side effects. Making comparisons is pointless.

Likewise C7. Atvb with today's appointment. I think Bill Shankly got it wrong. Nothing is more important than life, 'keep punching'.

leas

jtd's quite right. A few posters like yourself have found your input valuable. Only been invested prior to Ind-1 so any info. repeated or not is essential to the bb.

I just cannot see significant shareholders being kept in the dark. They must be aware of what is happening behind the scenes. They are not going to sit on this, especially with the huge potential.

Jimzi, HVO is nothing like MTFB. It's self funding, has other compounds in development and it's science is developed around Immutherapy. It is not toxic to vital organs and the trial designs are very much different to the ones undertaken by Motif.

I sold out last year with a small profit after being asked to dip my hand in my pockets twice for fund raising. The company on the last occasion raised funds at 31p when the sp was 39p. The discount to the city boys was too much.
I can see another discount placing coming up and hope those investors buying now know the history. That said, nice bounce yesterday but really hope it's not orchestrated in order to draw in pi's as the institutions dump their shares.

All the ii sized trades have been 17p on the nail. Same trend for quite a while. Will they be done by the market update on Cal-1? Would love to see an unexpected left of field positive RNS to drop in.

That coiled spring just keeps getting tighter.

SBB1, be careful with that reasoning. Institutions will want to lower their losses. Pi's getting suckered in on a dead cat. IMM had many investors suckered in at 29p and more recently out of the bio sector FLYB at 16p.

There may be other vaccines in development. Always have been. FLU-5 86% effective covers many strains and no annual repeat. Frustrating that we have no news atm on partnership or deal with another bio but they are not offering out their hat for shareholders for further development.

Timely reminder today with MTFB and the dangers of putting all their eggs in one basket and expect pi's to fund it as they continue to draw their high salaries.
I think Jimzi got caught out over there. Feel sorry for the Lth's as the traders move in and institution's dump their shares. Aim at it's best.

Rhodi, I also think the company and sp will make big strides too. All those ATs particularly prior to the market closing are to peg the price back so those shares on loan can be returned. Either that or orders being filled at an agreed price. Only speculative thoughts but there is no denying that the price is being manipulated for someone's gain.